6th -
7th
November 2024
November 2024 | 
Amari Bangkok, Thailand

SEA's ONLY vaccine conference from Discovery to Delivery

6th -
7th
November 2024 | 
Amari Bangkok, Thailand
📆 Add to Google Calendar
Attendees
0 +
Companies
0 +
Speakers
0 +
In-Person Networking Hours
0 +
Case Studies
0 +

South East Asia vaccine market is rapidly emerging as a significant player within the global vaccine industry, driven by increased investments, technological advancements, and governmental support. Countries such as Thailand, Indonesia, Malaysia, the Philippines, and Vietnam are leading the charge, offering unique advantages for major pharmaceutical and biopharmaceutical companies, including robust research capabilities and favorable regulatory environments. As the industry continues to expand, the region is poised to deliver even more exciting developments in vaccines.

Collaboration among South East Asian nations and international partners, coupled with efficient pandemic response measures and streamlined regulatory processes, further solidifies the region's position in vaccine development and distribution. The COVID-19 pandemic has particularly emphasized the market potential of South East Asia, showcasing its crucial role in addressing global health crises.

Vaccine World Asia Congress 2024 - South East Asia Focused stands as a premier destination for all things vaccine-related in the South East Asia region. It provides a vital platform for industry stakeholders to convene and explore the latest advancements in vaccine research and development within the region. Experts from Thailand, Malaysia, Indonesia, Vietnam, and beyond gather to discuss innovative manufacturing processes and cutting-edge technologies shaping the future of vaccines in South East Asia. With a focus on collaboration, knowledge exchange, and showcasing groundbreaking case studies, the conference are driven by a common goal: transforming innovative concepts into actionable solutions, accelerate research initiatives, bolster manufacturing capabilities, and integrate novel technologies to revolutionize vaccine development in the region.

FEATURED CONTENT

Untitled design
Indonesia & Malaysia In-Focus
Web Cover2
Key Vaccine Partnerships in SEA
Web Cover
Thailand's Vaccine Ecosystem
Web Cover
SEA Vaccine Directory
MicrosoftTeams-image (22)
Collaboration in Vaccine Research and Development in APAC
survey-banner
Survey Results 2024
VWA23_Ebook-website-cover-900-x-480
Unveiling the Future of Vaccines in Asia-Pacific
Screenshot-2023-10-03-135007
Fireside Chat - Perspectives on Emerging Technologies in Vaccine Development & Manufacturing
VWA23_Content-3-new-banner
Vaccine Development in the Asia-Pacific: Navigating Key Trends and Innovations
VWA23_-Vaccine-Innovator-website-cover-900-x-480
Infographic: Vaccine Innovators and Manufacturers in the Asia-Pacific Region
VWA23_Advancements-in-mRNA-1500x1500-1-1024x1024
Advancements in mRNA Technology: Unlocking Potential in the APAC Region
MicrosoftTeams-image-2022-07-28T154253.666
New MRNA Vaccine Modalities
Vaccine World Asia Congress 2024 – South East Asia Focused

.

.

.

.

.

.

.

.

THANK YOU TO OUR SUPPORTING PARTNERS









2024

SPEAKERS

Featuring esteemed voices from the biopharmaceutical sector. Our selected experts will share insights on the latest trends, challenges, and developments in this dynamic field. Engage in unique discussions, learn about cutting-edge scientific discoveries, and explore the future of biopharmaceuticals with these influential thought leaders. Don't miss this chance to broaden your understanding of this ever-evolving industry.

S. Alonso (3)

A/Prof. Sylvie Alonso

Infectious Diseases Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore; Vaccines & Therapeutics Co-operative Lead, PREPARE, National Centre for Infectious Diseases

Ministry of Health, Singapore
Singapore
Alap Gandhi_GSK

Alap Gandhi

Country Medical Director -Malaysia & Brunei

GSK
Malaysia
Chunlin Xin Speaker Head 1

Chunlin Xin

Vice President

CanSino Biologics Inc.
China
KIMHUN

Dr Hun Kim

President/Global R&BD

SK Bioscience
Korea
no-picture

Dr. Ajay Singh

Head- mRNA Department

Gennova Biopharmaceuticals
India
Badarulhisam Abdul Rahman_Pharmaniaga

Dr. Badarulhisam Abdul Rahman

Chief Scientific Officer

Pharmaniaga
Malaysia
Dr Nakorn's Photograph

Dr. Nakorn Premsri

Director

National Vaccine Institute
Thailand
Dr. Nguyen Tuyet Nga

Dr. Nguyen Tuyet Nga

South East Asia Hub Director/ Vietnam Country Director

PATH
Vietnam
Dr.Nirutti's Photo

Dr. Nirutti Pradubyati

Medical Director

Pfizer
Thailand and Indochina
Dr. Philipp Lambach_WHO

Dr. Philipp Lambach

Team Lead Value of Vaccines, a.i.,

WHO
Switzerland
Leon-Cruz_photo_profile-3

Leon Cruz

Head of Production,

Duopharma Biotech Berhad
Malaysia 
no-picture

Luigi Bonfatti

Executive Advisor and Industry Engagement Lead

RVMC
Norway
Mark Pfizer (35)

Mark Kuo

Country Manager

Pfizer
Thailand
WhatsApp Image 2024-09-18 at 12.03.08 PM (1)

Mukesh Chauhan

Associate Production Director

BioNet Asia
Thailand
Nikolai Petrovsky

Nikolai Petrovsky

Chairman & Research Director

Vaxine Pty Ltd
Australia
C__Users_admin_Desktop_passport_dp

Prasen Adya

Dy General Manager

Serum Institute of India
India
Jetsumon-Sattabongkot-Prachumsri

Prof. Dr. Jetsumon Sattabongkot Prachumsri

Director

Mahidol Vivax Research Unit
Thailand
Prof. Dr. Sumana Knomvilai

Prof. Dr. Sumana Khomvilai

Consultant

National Vaccine Institute
Thailand
Prof.-Kiat-Ruxrungtham

Prof. Kiat Ruxrungtham

Co-director, Chula Vaccine Research Center / Director of School of Global Health

Chulalongkorn University
Thailand
Annual conference hosted at the Wellcome Trust Sanger Institute where the Malaria Genomic Epidemiology Network community of researchers work together through a series of multi-centre projects to understand how genome variation in human, Plasmodium and Anopheles populations affects the biology and epidemiology of malaria, and to use this knowledge to develop improved tools for controlling malaria.  Hinxton, Cambridgeshire 2015.

Professor Richard Maude

Head of Epidemiology Department

Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University
Thailand
Ravi-Ganapathy_photo_profile

Ravi Ganapathy

Director, R&D CMC

Hilleman Laboratories
Singapore
Soleh Ayubi profile

Soleh Ayubi

Deputy Chief Executive Officer (D/CEO)

PT Biofarma
Indonesia
Suthira Taychakhoonavudh

Suthira Taychakhoonavudh

CEO

Baiya Phytopharm
Thailand
image004

Tshering Sherpa

Associate Director of Business Development

WuXi Biologics
USA

DELEGATE REGISTRATION

Catch the limited super access in time to save BIG!

END-USERS
SGD 2,395

Late Kate
(until 7th November 2024)

*END-USER PRICING IS APPLICABLE to :

Company Profiles: Asian and International Biopharma, BIG Pharmas, Asian Academic & Research Institutes.

Job Profiles: Manufacturing, Bioprocessing, Production, USP, DSP, Operations, Site Heads, Drug Substance and Product Manufacturing, Process Development, Quality, Analytics and other related technical designations.

SERVICE/SOLUTION PROVIDER/BIG PHARMA
SGD 4,295

Late Kate
(
until 7th November 2024)

*SOLUTION PROVIDER PRICING IS APPLICABLE to

Company Profile: Technology and Solutions Provider, Asian/International Biopharma, BIG Pharmas, CMO’s, Asian Academic/Research Institutes.

Job Profiles: Business Development, Marketing & Sales

DELEGATE REGISTRATION

Catch the limited super access in time to save BIG!

END-USERS
SGD 2,395

Late Kate
(until 7th November 2024)

*END-USER PRICING IS APPLICABLE to :

Company Profiles: Asian and International Biopharma, BIG Pharmas, Asian Academic & Research Institutes.

Job Profiles: Manufacturing, Bioprocessing, Production, USP, DSP, Operations, Site Heads, Drug Substance and Product Manufacturing, Process Development, Quality, Analytics and other related technical designations.

SERVICE/SOLUTION PROVIDER/BIG PHARMA
SGD 4,295

Late Kate
(
until 7th November 2024)

*SOLUTION PROVIDER PRICING IS APPLICABLE to

Company Profile: Technology and Solutions Provider, Asian/International Biopharma, BIG Pharmas, CMO’s, Asian Academic/Research Institutes.

Job Profiles: Business Development, Marketing & Sales

What's New
  • Over 95% of C-Level speakers from leading SEA biopharma, pharma & government regulators will be presenting at the conference.
  • Capable of engaging with ministries from the key countries such as Thailand, Cambodia, Malaysia and the FDA across the Southeast Asian region.
  • Participate in 7 roundtable discussions covering the latest challenges faced by companies in Southeast Asia from partnership & financing, safety manufacturing to market access led by SEA biopharma thought leaders.
  • Discover SEA's modern, leading-edge technologies in vaccine R&D, latest manufacturing hurdles, mRNA platform enhancements, managing supply demand and last-mile delivery.
  • Network with 300+ decision-makers from the leading 100 vaccine companies and esteemed government regulatory bodies, including the US FDA and key regulators across South East Asia and APAC.
  • Top vaccine solution providers, including Wuxi Vaccine, MasterControl, Tofflon, P95, BatchLine, and more will be exhibiting and showcasing the latest technologies at the event.
  • Facilitate working group discussions with industry professionals in this powerful, interactive format.
  • 100% of the audience will be coming from SEA from the job title of CEOs, CSOs, CTOs, VPs, Executive Director and Heads of Departments from: Manufacturing, Operations, Technical Operations, Process Development, R&D, Clinical Trials, Logistics & Supply Chain Management.
  • 80+ emerging and leading SEA biopharma from  Manufacturing, Operations, Technical Operations, Process Development, R&D, Clinical Trials, Logistics & Supply Chain Management have been invited to the conference.
PRE CONFERENCE WORKSHOP

FEATURED CONTENT

Untitled design
Indonesia & Malaysia In-Focus
Web Cover2
Key Vaccine Partnerships in SEA
Web Cover
Thailand's Vaccine Ecosystem
Web Cover
SEA Vaccine Directory
MicrosoftTeams-image (22)
Collaboration in Vaccine Research and Development in APAC
survey-banner
Survey Results 2024
VWA23_Ebook-website-cover-900-x-480
Unveiling the Future of Vaccines in Asia-Pacific
Screenshot-2023-10-03-135007
Fireside Chat - Perspectives on Emerging Technologies in Vaccine Development & Manufacturing
VWA23_Content-3-new-banner
Vaccine Development in the Asia-Pacific: Navigating Key Trends and Innovations
VWA23_-Vaccine-Innovator-website-cover-900-x-480
Infographic: Vaccine Innovators and Manufacturers in the Asia-Pacific Region
VWA23_Advancements-in-mRNA-1500x1500-1-1024x1024
Advancements in mRNA Technology: Unlocking Potential in the APAC Region
MicrosoftTeams-image-2022-07-28T154253.666
New MRNA Vaccine Modalities

Don't Just Take Our Word For It

HEAR FROM OUR CLIENTS

“Very informative and good opportunity for networking.” 

Roche,  
 

“Enriching perspectives about vaccines development shared between academia and industry.” 

Qatar University,  
 

“Great lineup of leaders. Their sometimes contradictory positions provided extra value as seeing probing arguments on both sides of a topic.” 

Provaxus,  
 

“IMAPAC does a great job of bringing a lot of regional players to one event and we’ve benefitted from speaking to a lot of decision-makers from Vaccine manufacturers around Asia, particularly India, Korea, Singapore and some from Australia as well.” 

MasterControl,  
 

“There have been great speakers, and in particular, great audience participation, which is a key aspect to a successful meeting, and at the tea breaks and lunch there have been fabulous opportunities for networking. This conference is important because it really brings together the regional players in the vaccine space, so you get to meet different people from organisations within SEA particularly and get their insights into what’s happening in Vaccines. If you go to a US meeting you won’t get that perspective. So that’s why I come to meetings like this one to find out what’s happening in this part of the world.”

Vaxine Pty Ltd, Australia,  
 

The conference was a rewarding experience, with insightful presentations. The intimate setting fostered personal interactions and meaningful discussions, enhancing the overall learning experience.

University of Queensland, Australia,  
 

#BUZZ ABOUT THE EVENT

SIMILAR EVENTS

Register Now. SAVE BIG!

Download Post Event Report Form

Download Participating Companies

IMAPAC requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and to learn more about our privacy practices and our commitment to protecting your privacy, please review our Privacy Policy.

Download Attendee List

Download Prospectus Document Form

Brochure Form

Sponsorship Form

IMAPAC requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and to learn more about our privacy practices and our commitment to protecting your privacy, please review our Privacy Policy.

Download Agenda Form

Apply For Speaking Opportunity

Featured Content Form

Download List of Biopharma Companies in Asia Brochure

Download Ebook

Download Ebook

VWSEA2024 Brochure

Download List of Biopharma, CMO, CRO, CDMO and Big Pharma in China and Taiwan Brochure

Download Strategic Consulting Brochure

Download Case Study Consulting Digital Disruption

Download Case Study Consulting Revolutionizing Biopharmaceuticals

Download IMAPAC Custom Events Prospectus

Download Case Study : Fill-Finish Solution provider increasing its market share

Download Case Study : European CMO expanding into APAC

Download Case Study : China CDMO's New Gene Protein Facility Opening

Download Biologics Newsletter

Download Cell and Gene Therapy Newsletter

Download Vaccines Newsletter

Download 1:1 Networking Meetings Case Study- High-end assembly solutions provider

Download 1:1 Networking Meetings Case Study- IT/Software Solution provider

Download 1:1 Networking Meetings Case Study